XyloCor reports positive data from refractory angina gene therapy trial
Participants treated with XC001 showed improvements in ischaemic burden and total exercise duration.
Participants treated with XC001 showed improvements in ischaemic burden and total exercise duration.
The trial will assess the safety and pharmacokinetics of Orladeyo in paediatric HAE patients.
Data from the TRANSCEND CLL 004 trial showed that the study met the primary endpoint of complete response rate.
At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.
According to GlobalData’s Pharmaceutical Intelligence Center, obeticholic acid currently has a 64% likelihood of FDA approval.
How can gene therapy trials choose the best endpoints to navigate development and demonstrate patient value?
From bypassing animal testing to forecasting outcomes, we review some of the latest use cases of predictive analytics in drug development.
The trial assessed the safety and efficacy of IV SPL026 with supportive therapy in 34 MDD patients.
Studies have shown MDD can worsen multiple sclerosis symptoms, reduce quality of life, and accelerate death in patients.
Elon Musk has espoused Novo Nordisk’s Wegovy to his Twitter followers, with Kim Kardashian also rumoured to have used the drug.
DB-OTO is being developed by Decibel, in partnership with Regeneron Pharmaceuticals.
The trial will assess pitolisant’s efficacy and safety in Japanese OSAS patients who are complaining of EDS.
The trial will include healthy subjects aged 18 to 55 years who will be randomised in 4:1 ratio, with 15 subjects per cohort.
Tris Pharma and Wex Pharmaceuticals are two of the companies with novel therapies for pain currently undergoing clinical trials.
Malaria is mosquito-bourne disease caused by infection with the Plasmodium parasite.
ALTB-268 helps to restore the immune system to a state of balance.